Uric Acid, CKD, and Cardiovascular Disease: Confounders, Culprits, and Circles

Overview

Journal Am J Kidney Dis

Specialty Nephrology

Date 2010 Jul 28

PMID 20659624

Citations 15

Authors

Navdeep Tangri

Daniel E Weiner

Affiliations

Soon will be listed here.

Citing Articles

Uric Acid and Risk of Cardiovascular Disease and Mortality: A Longitudinal Cohort Study.

Kim J, Seo C, Pak H, Lim H, Chang T J Korean Med Sci. 2023; 38(38):e302.

PMID: 37750373 PMC: 10519779. DOI: 10.3346/jkms.2023.38.e302.

Assessment of the efficacy of hemodialysis on uric acid clearance in a sub-Saharan African population at the end stage kidney disease.

Doualla M, Nkeck J, Halle M, Kamdem F, Agouak A, Essouma M BMC Nephrol. 2020; 21(1):378.

PMID: 32867705 PMC: 7457757. DOI: 10.1186/s12882-020-02037-8.

Clinical relevance of serum uric acid and abdominal aortic-calcification in a national survey.

Li Y, Chen W Clin Cardiol. 2020; 43(10):1194-1201.

PMID: 32720347 PMC: 7533967. DOI: 10.1002/clc.23433.

Association of Serum Uric Acid Concentration and Its Change with Cardiovascular Death and All-Cause Mortality.

Dong Z, Tian M, Li H, Wu Y, Du X, Dong J Dis Markers. 2020; 2020:7646384.

PMID: 32076464 PMC: 7008257. DOI: 10.1155/2020/7646384.

Plasma uric acid and renal haemodynamics in type 2 diabetes patients.

Suijk D, Smits M, Muskiet M, Tonneijck L, Kramer M, Joles J Nephrology (Carlton). 2019; 25(4):290-297.

PMID: 31429150 PMC: 7065078. DOI: 10.1111/nep.13645.

References

Christenfeld N, Sloan R, Carroll D, Greenland S . Risk factors, confounding, and the illusion of statistical control. Psychosom Med. 2004; 66(6):868-75. DOI: 10.1097/01.psy.0000140008.70959.41. View

Siu Y, Leung K, Ka-Hang Tong M, Kwan T . Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Dis. 2005; 47(1):51-9. DOI: 10.1053/j.ajkd.2005.10.006. View

Wen C, Cheng T, Chan H, Tsai M, Chung W, Tsai S . Is high serum uric acid a risk marker or a target for treatment? Examination of its independent effect in a large cohort with low cardiovascular risk. Am J Kidney Dis. 2010; 56(2):273-88. DOI: 10.1053/j.ajkd.2010.01.024. View

Talaat K, el-Sheikh A . The effect of mild hyperuricemia on urinary transforming growth factor beta and the progression of chronic kidney disease. Am J Nephrol. 2007; 27(5):435-40. DOI: 10.1159/000105142. View

Kanellis J, Kang D . Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease. Semin Nephrol. 2005; 25(1):39-42. DOI: 10.1016/j.semnephrol.2004.09.007. View

Mazzali M, Hughes J, Kim Y, Jefferson J, Kang D, Gordon K . Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension. 2001; 38(5):1101-6. DOI: 10.1161/hy1101.092839. View

Bellomo G, Venanzi S, Verdura C, Saronio P, Esposito A, Timio M . Association of uric acid with change in kidney function in healthy normotensive individuals. Am J Kidney Dis. 2010; 56(2):264-72. DOI: 10.1053/j.ajkd.2010.01.019. View

Weiner D, Tighiouart H, Elsayed E, Griffith J, Salem D, Levey A . Uric acid and incident kidney disease in the community. J Am Soc Nephrol. 2008; 19(6):1204-11. PMC: 2396939. DOI: 10.1681/ASN.2007101075. View

Lehto S, Niskanen L, Ronnemaa T, Laakso M . Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus. Stroke. 1998; 29(3):635-9. DOI: 10.1161/01.str.29.3.635. View

10.

Niskanen L, Laaksonen D, Nyyssonen K, Alfthan G, Lakka H, Lakka T . Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med. 2004; 164(14):1546-51. DOI: 10.1001/archinte.164.14.1546. View

11.

Feig D, Soletsky B, Johnson R . Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. JAMA. 2008; 300(8):924-32. PMC: 2684336. DOI: 10.1001/jama.300.8.924. View

12.

Mercuro G, Vitale C, Cerquetani E, Zoncu S, Deidda M, Fini M . Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk. Am J Cardiol. 2004; 94(7):932-5. DOI: 10.1016/j.amjcard.2004.06.032. View

13.

Remuzzi G, Perico N, Macia M, Ruggenenti P . The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease. Kidney Int Suppl. 2005; (99):S57-65. DOI: 10.1111/j.1523-1755.2005.09911.x. View

14.

Doehner W, Schoene N, Rauchhaus M, Leyva-Leon F, Pavitt D, Reaveley D . Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies. Circulation. 2002; 105(22):2619-24. DOI: 10.1161/01.cir.0000017502.58595.ed. View

15.

Feig D, Kang D, Johnson R . Uric acid and cardiovascular risk. N Engl J Med. 2008; 359(17):1811-21. PMC: 2684330. DOI: 10.1056/NEJMra0800885. View

16.

Culleton B, Larson M, Kannel W, Levy D . Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med. 1999; 131(1):7-13. DOI: 10.7326/0003-4819-131-1-199907060-00003. View

17.

Elsayed E, Tighiouart H, Griffith J, Kurth T, Levey A, Salem D . Cardiovascular disease and subsequent kidney disease. Arch Intern Med. 2007; 167(11):1130-6. DOI: 10.1001/archinte.167.11.1130. View

18.

Kang D, Nakagawa T, Feng L, Watanabe S, Han L, Mazzali M . A role for uric acid in the progression of renal disease. J Am Soc Nephrol. 2002; 13(12):2888-97. DOI: 10.1097/01.asn.0000034910.58454.fd. View

19.

Puig J, Anton F, Alonso-Vega G . Renal handling of uric acid: hypouricemia and tubular urate secretion. Arch Intern Med. 1986; 146(9):1865. View

20.

McNamee R . Confounding and confounders. Occup Environ Med. 2003; 60(3):227-34; quiz 164, 234. PMC: 1740493. DOI: 10.1136/oem.60.3.227. View